Pasithea Therapeutics Corp Stock Forecast, Predictions & Price Target

Analyst price target for KTTA

Based on 1 analyst offering 12 month price targets for Pasithea Therapeutics Corp.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell KTTA stock?

Based on 1 analyst offering ratings for Pasithea Therapeutics Corp.
Strong Buy
Strong Buy
1 analysts 100%
0 analysts 0%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their KTTA stock forecasts and price targets.

KTTA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color

1 of 1

KTTA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KTTA$0.33$2.00+502.41%Strong Buy
CMMB$0.56$7.00+1,152.24%Strong Buy

Pasithea Therapeutics Stock Forecast FAQ

Is Pasithea Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: KTTA) stock is to Strong Buy KTTA stock.

Out of 1 analyst, 1 (100%) are recommending KTTA as a Strong Buy, 0 (0%) are recommending KTTA as a Buy, 0 (0%) are recommending KTTA as a Hold, 0 (0%) are recommending KTTA as a Sell, and 0 (0%) are recommending KTTA as a Strong Sell.

If you're new to stock investing, here's how to buy Pasithea Therapeutics stock.

What is KTTA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year KTTA price target, the average KTTA price target is $2.00, with the highest KTTA stock price forecast at $2.00 and the lowest KTTA stock price forecast at $2.00.

The Wall Street analyst predicted that Pasithea Therapeutics's share price could reach $2.00 by Jul 10, 2024. The average Pasithea Therapeutics stock price prediction forecasts a potential upside of 502.41% from the current KTTA share price of $0.33.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.